Kyoto Biken Laboratories (Japan)

Recent papers from Kyoto Biken Laboratories (Japan)

1. Development and Evaluation of the Drape by Bond (D-by-B) Technique for Maintaining Preoperative Disinfection During Laparotomy in CattleJapanese Journal of Large Animal Clinics · 2025
2. Efficacy and Limitations of an Improved Vaccine Derived from an Updated Vaccine Strain Against H5 HighPathogenicity Avian InfluenzaVaccines · 2026
3. Targeting fibroblast activation protein in solid tumors via LNP-mediated CAR-mRNA delivery promotes durable regression in murine modelsScientific Reports · 2025
4. Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variants.2025
5. Codon-deoptimized single-round infectious virus for therapeutic and vaccine applicationsScientific Reports · 2025
6. Aging and inflammation limit the induction of SARS-CoV-2–specific CD8+ T cell responses in severe COVID-19JCI Insight · 2025
7. Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid NanoparticlesMolecular Pharmaceutics · 2024
8. Extracellular Vesicle Inhibitors Enhance Cholix-Induced Cell Death via Regulation of the JNK-Dependent PathwayToxins · 2024
9. Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis-associated thymomaCell Reports · 2024
10. 1mΨ influences the performance of various positive-stranded RNA virus-based repliconsScientific Reports · 2024
11. Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine AntigenACS Nano · 2024
12. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trialBMC Oral Health · 2024
13. JAK inhibition during the early phase of SARS-CoV-2 infection worsens kidney injury by suppressing endogenous antiviral activity in miceAJP Renal Physiology · 2024
14. Development and Application of Attenuated Plant Viruses as Biological Control Agents in JapanViruses · 2024
15. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavageMicrobiology Spectrum · 2024
16. Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domainMicrobiology Spectrum · 2024
17. Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipientsCommunications Medicine · 2024
18. Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responsesJournal of Clinical Investigation · 2023
19. α-Glucosidase inhibitors boost gut immunity by inducing IgA responses in Peyer’s patchesFrontiers in Immunology · 2023
20. A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in miceFrontiers in Immunology · 2023